7 Results

People

  1. Arbour
    Arbour
  2. Drilon
    Drilon
  3. Lai
    Lai
  4. Kris
    Kris
  5. Li
    Li
  6. Offin
    Offin
  7. Riely
    Riely
  8. Hellmann
    Hellmann
  9. Sabari
    Sabari
  10. Bergagnini
    Bergagnini

Groups

  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (7)
  4. Epidemiology and Biostatistics (5)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  6. Biostatistics Service (4)
  7. GSK Faculty (4)
  8. Radiology, Department of (3)
  9. Body Imaging Service (2)
  10. Center for Pancreatic Cancer Research (2)
  1. "Department of Medicine"
  2. "Alexander Drilon"
  3. "Kathryn Arbour"
  4. "Wei-Chu Lai"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. Solid Tumor Oncology Division (7)
  3. Thoracic Oncology (7)
  4. Epidemiology and Biostatistics (5)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  6. Biostatistics Service (4)

More Groups

People
  1. Alexander Drilon (7)
  2. Kathryn Arbour (7)
  3. Wei-Chu Lai (7)
  4. Bob Li (5)
  5. Gregory Riely (5)
  6. Mark Kris (5)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2018 (3)
  4. 2017 (2)
Publications
  1. Annals of Oncology (2)
  2. Journal of Clinical Oncology (2)
  3. Current Oncology Reports (1)
  4. Nature Medicine (1)
  5. OncoTargets and Therapy (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Oxford University Press (2)
  3. Dove Medical Press Ltd (1)
  4. Nature Publishing Group (1)
  5. Springer (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • COVID-19 in patients with lung cancer
    Journal Article

    Luo, J.; Rizvi, H.; Preeshagul, I. R.; Egger, J. V.; Hoyos, D.; Bandlamudi, C.; McCarthy, C. G.; Falcon, C. J.; Schoenfeld, A. J.; Arbour, K. C.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
    Journal Article

    Sabari, J. K.; Santini, F. C.; Schram, A. M.; Bergagnini, I.; Chen, R.; Mrad, C.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    OncoTargets and Therapy (2017)

    Fulltext@MSK | Save
  • Changing the therapeutic landscape in non-small cell lung cancers: The evolution of comprehensive molecular profiling improves access to therapy
    Journal Article

    Sabari, J. K.; Santini, F.; Bergagnini, I.; Lai, W. V.; Arbour, K. C.; Drilon, A.
    Current Oncology Reports (2017)

    Fulltext@MSK | Save